MapLight (NASDAQ: MPLT) grants CEO 93,955 options and 23,145 RSUs
Rhea-AI Filing Summary
MapLight Therapeutics, Inc. (MPLT) reported that its Chief Executive Officer and director, Christopher A. Kroeger, received equity awards on August 17, 2026. He was granted an option to purchase 93,955 shares of voting common stock at an exercise price of $11.245 per share, expiring August 16, 2036; one quarter of these option shares vest on July 1, 2027, and the rest in equal monthly installments thereafter, subject to continued service. He also received 23,145 restricted stock units, each representing one share of voting common stock, with one quarter vesting on July 1, 2027 and the remainder in equal quarterly installments, also subject to continued service. Following these awards he directly holds 1,269,600 shares of voting common stock, and an additional 101,190 shares are held indirectly through the C&M Kroeger Nominee Trust, where he and his spouse serve as co-trustees with voting and dispositive power.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 23,145 shares
Net Buy
3 txns
Insider
Kroeger Christopher A.
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) F4 | 93,955 | $0.00 | $0.00 |
| Grant/Award | Voting Common Stock F1, F2 | 23,145 | $0.00 | $0.00 |
| holding | Voting Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Employee Stock Option (right to buy) — 93,955 shares (Direct);
Voting Common Stock — 1,269,600 shares (Direct);
Voting Common Stock — 101,190 shares (Indirect, See footnote)
Footnotes (4)
- F1. Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date.
- F2. Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
- F3. The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.
- F4. 1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Key Figures
Stock options granted: 93,955 shares
Option exercise price: $11.245 per share
Option expiration date: August 16, 2036
+5 more
8 metrics
Stock options granted
93,955 shares
Employee Stock Option grant to CEO on August 17, 2026
Option exercise price
$11.245 per share
Exercise price for 93,955-share option grant
Option expiration date
August 16, 2036
Expiration of CEO stock option grant
RSUs granted
23,145 units
Restricted stock unit award to CEO on August 17, 2026
Direct shares held after transaction
1,269,600 shares
CEO direct ownership of voting common stock following reported awards
Indirect shares held via trust
101,190 shares
Voting common stock held by C&M Kroeger Nominee Trust
Initial option vesting date
July 1, 2027
First vesting date for 93,955-share option grant
Initial RSU vesting date
July 1, 2027
First vesting date for 23,145 RSU award
Key Terms
restricted stock unit ("RSU"), voting common stock, Employee Stock Option (right to buy), dispositive power
4 terms
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest"
voting common stock financial
"Each RSU represents a contingent right to receive one share of voting common stock"
Employee Stock Option (right to buy) financial
"security_title": "Employee Stock Option (right to buy)"
dispositive power financial
"co-trustee with his spouse and has voting and dispositive power."
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
FAQ
What insider equity awards did MPLT CEO Christopher A. Kroeger receive on August 17, 2026?
Christopher A. Kroeger received an option for 93,955 shares at $11.245 per share and 23,145 restricted stock units. Both awards vest over time starting July 1, 2027, conditional on his continued service with MapLight Therapeutics.
What is the vesting schedule of the new stock options granted to MPLT’s CEO?
The 93,955-share option vests 1/4 on July 1, 2027, with the remaining 3/4 vesting in equal monthly installments thereafter. Each monthly vesting is subject to Christopher A. Kroeger’s continued service through the applicable vesting date.
How do the MPLT CEO’s new RSUs vest?
The 23,145 RSUs vest 1/4 on July 1, 2027, and 1/16 on each subsequent October 1, January 1, April 1, and July 1. Vesting is contingent on Christopher A. Kroeger’s continued service through each scheduled vesting date.
What are Christopher A. Kroeger’s direct common stock holdings in MPLT after these transactions?
After these awards, Christopher A. Kroeger directly holds 1,269,600 shares of MapLight Therapeutics voting common stock. This figure excludes indirect holdings through any trusts or other entities associated with him.
When do the newly granted MPLT stock options to the CEO expire?
The option to acquire 93,955 MPLT shares granted to Christopher A. Kroeger expires on August 16, 2036. The option remains exercisable according to its terms, including vesting and continued-service conditions detailed in the award description.
AI-generated analysis. How Rhea-AI works. Not financial advice.
